Match!
Aly El-Banayosy
Pennsylvania State University
203Publications
32H-index
3,653Citations
Publications 203
Newest
#1Dirk Pabst (Penn State Milton S. Hershey Medical Center)H-Index: 2
#2Aly El-Banayosy (Integris Baptist Medical Center)H-Index: 32
Last.Christoph Brehm (Penn State Milton S. Hershey Medical Center)H-Index: 6
view all 4 authors...
#1Michael M. KoernerH-Index: 20
#2Aly El-Banayosy (Integris Baptist Medical Center)H-Index: 32
#1Ali Ghodsizad (Penn State Milton S. Hershey Medical Center)H-Index: 7
#2Michael M. KoernerH-Index: 20
Last.Matthias Loebe (Penn State Milton S. Hershey Medical Center)H-Index: 15
view all 6 authors...
The SynCardia Total Artificial Heart (TAH) has been used for patients with biventricular failure, who cannot be managed with implantation of a left ventricular (LV) assist device. Following TAH implantation, our patient developed severe hemolysis, which could only be managed successfully by aggressive blood pressure control [Ohashi 2003; Nakata 1998].
#1Dirk Pabst (Penn State Milton S. Hershey Medical Center)H-Index: 2
#2Ali Ghodsizad (Penn State Milton S. Hershey Medical Center)H-Index: 7
Last.Christoph Brehm (Penn State Milton S. Hershey Medical Center)H-Index: 6
view all 5 authors...
#1Nadia AissaouiH-Index: 11
#2Christoph BrehmH-Index: 1
Last.AlainCombesH-Index: 1
view all 4 authors...
Background: Significant advances in extracorporeal technology have led to the more widespread use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for cardiac failure. However, procedures for weaning from VA ECMO are not standar‐ dized. High death rate after successful weaning shows that many questions remain unresolved in this field. Objectives: In this review, we discuss data from the literature and propose a strategy to optimize the weaning process. Data synthesis and conclusion...
#1Michael M. Koerner (Integris Baptist Medical Center)H-Index: 20
#2Aly El-Banayosy (Integris Baptist Medical Center)H-Index: 32
Last.Ali Ghodsizad (Penn State Milton S. Hershey Medical Center)H-Index: 7
view all 7 authors...
Nocardia has emerged as an important opportunistic pathogen, especially in organ transplant recipients. Heart transplant (HT) recipients initially had an especially high rate of Nocardia infection, but this could be reduced by the routine use of cyclosporine. Our objective was to clarify the prevalence and presentation of Nocardiosis in HT recipients in a retrospective cross-sectional analysis.
#1Daniel Calderon (PSU: Pennsylvania State University)H-Index: 1
#2Aly El-Banayosy (PSU: Pennsylvania State University)H-Index: 32
Last.Faisal Aziz (PSU: Pennsylvania State University)H-Index: 15
view all 5 authors...
Extracorporeal membrane oxygenation (ECMO) is generally used as a last resort to provide cardiopulmonary support in patients whose advanced cardiac or respiratory failure does not respond to less invasive treatments. Lower-limb ischemia secondary to the large diameter of the arterial cannula is one of ECMO's major limitations: in patients who have small-caliber arteries, the cannulas can reduce native blood flow. The creation of a T-graft—a well-described technique to avoid limb ischemia—enables...
#1B. Soleimani (Penn State Milton S. Hershey Medical Center)H-Index: 8
#2Edward R. Stephenson (Penn State Milton S. Hershey Medical Center)H-Index: 14
Last.Walter E. Pae (Penn State Milton S. Hershey Medical Center)H-Index: 30
view all 5 authors...
Background The safety and efficacy of exchanging the HeartMate II (Thoratec Corp, Pleasanton, CA) left ventricular assist device (LVAD) through a less invasive subcostal approach remains unclear. Methods We reviewed the records of 17 patients who underwent exchange of their HeartMate II device at our institution since 2007. We divided the cohort into devices exchanged through a subcostal (SC) approach versus a median sternotomy (MS) approach and obtained data pertaining to the short- and long-te...
12345678910